z-logo
Premium
P099: Flunarizine, a clinically licensed diphenylmethylpiperazine and T‐type calcium channel inhibitor prevents Hepatitis C virus membrane fusion in a genotype‐dependent manner
Publication year - 2015
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.93_12425
Subject(s) - flunarizine , virology , hepatitis c virus , medicine , calcium channel , genotype , virus , calcium , biology , genetics , gene

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom